stockrowASP Isotopes Inc.
ASPI Basic Materials Specialty Chemicals
ASP Isotopes Inc.’s revenue for fiscal 2025 (year ended December 2025) was $23.8 million, up 475.5% from fiscal 2024.
- Revenue
- +327.6%
- EPS
- +73.8%
- Free cash flow
- −182.9%
- Total debt
- +162.4%
Quarter to June 2026, against a year earlier
Follow ASPI
Alert me
ASP Isotopes Inc. (ASPI) EV/Sales
As of 5 November 2026, ASP Isotopes Inc. (ASPI) trades at a EV/Sales of 7.0×. Over the past ten years it has ranged from 0.0× (December 2024) to 189× (September 2025); the current reading is higher than 54% of that period. That is above the Specialty Chemicals industry median of 1.9× and above the Basic Materials sector median of 1.8×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 13.4× | (75.57%) |
| FY2024 | 54.7× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 24.9× | 33.98% |
| Mar 2026 | 18.6× | 39.02% |
| Dec 2025 | 13.4× | (86.88%) |
| Sep 2025 | 102× | (18.15%) |
| 6 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ALTO Alto Ingredients, Inc. compare | 0.3× |
| OEC Orion S.A. compare | 0.6× |
| CMT Core Molding Technologies Inc compare | 0.6× |
| HDSN Hudson Technologies, Inc. compare | 0.7× |
| FF FutureFuel Corp. compare | 1.3× |
| ASPN Aspen Aerogels, Inc. compare | 1.7× |
| MNTK Montauk Renewables, Inc. compare | 2.5× |
| GEVO Gevo, Inc. compare | 2.6× |
| ASPI ASP Isotopes Inc. | 7.0× |
| Specialty Chemicals industry median | 1.9× |
| Basic Materials sector median | 1.8× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)